Interrelationships among mortality rates, drug costs, total cost of care, and length of stay in United States hospitals: Summary and recommendations for clinical pharmacy services and staffing

Pharmacotherapy

Volumn 21, Issue 2, 2001, Pages 129-141

  Bond, C A ^a   Raehl, C L ^b   Franke, T ^b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Texas Tech School of Pharmacy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PHARMACY; CLINICAL PROTOCOL; DRUG COST; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HOSPITALIZATION; LENGTH OF STAY; MEDICAL STAFF; MORTALITY; UNITED STATES;

COST SAVINGS; DRUG COSTS; HEALTH CARE COSTS; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; OUTCOME ASSESSMENT (HEALTH CARE); PHARMACISTS; PHARMACY SERVICE, HOSPITAL; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX;

EID: 0035150656     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.21.2.129.34105     Document Type: Article

References (64)

1. The relationship of hospital characteristics and results of peer review in six large hospitals
2. Analyzing hospital mortality - The consequences of diversity in patient mix
3. A national validation study of Medicare mortality studies (project #1247-M)
4. Hospital characteristics and mortality rates
5. Physician and hospital factors associated with mortality in surgical patients
6. Hospital and pharmacy characteristics associated with mortality rates in United States hospitals
7. Health care professional staffing, hospital characteristics, and hospital mortality rates
8. Clinical pharmacy services and hospital mortality rates
9. Clinical pharmacy services, pharmacist staffing, and drug costs in United States hospitals
10. Clinical pharmacy services, pharmacy staffing, and the total cost of care in United States hospitals
11. An eleven-year review of the pharmacy literature: Documentation of the value and acceptance of clinical pharmacy
12. Medication distribution systems
13. Influence of clinical pharmacists consultations on the use of blood level test
14. Establishing an aminoglycoside pharmacokinetic monitoring service in a community hospital
15. Use of clinical pharmacists to reduce cefamandole, cefoxitin, and ticarcillin costs
16. Pharmacists' monitoring of parenteral nutrition: Clinical and cost effectiveness
17. Impact of docent clinical pharmacists on treatment of streptococcal pneumonia
18. Fluphenazine out-patient clinics: A pharmacist's role
19. Effect of clinical pharmacy services on prescribing on an orthopedic unit
20. Improving drug-therapy decisions through educational outreach: A randomized controlled trial of academically based "detailing
21. Relationship of inappropriate drug prescribing to increased length of hospital stay
22. Drug prescribing and its relationship to length of hospital stay
23. Effect of advanced pharmaceutical services on the incidence of adverse drug reactions
24. Economic consequences of two drug-use control systems in a teaching hospital
25. Effect of pharmacist on health care outcomes in hospitalized patients
26. The impact of clinical pharmacists on psychiatric patients
27. Role of the clinical pharmacist in improving out-patient drug therapy
28. Sustained improvement in drug documentation, compliance, and disease control - A four year ambulatory care model
29. Effectiveness of clinical phamacist interventions in a hemodialysis unit
30. Pharmacist participation on a multidisciplinary rehabilitation team
31. Case mix, costs, and outcomes between faculty and community services in a university hospital
32. Hospital output forecasts and the cost of empty hospital beds
33. The relationship of hospital staff experiences to the cost and quality of inpatient care
34. The impact of case-mix on hospital costs: A comparative analysis
35. Economic evaluation of clinical pharmacy services - 1988-1995
36. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure team
37. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit
38. 1992 National clinical pharmacy services study
39. Hospital pharmacy services in the Great Lakes region
40. Pharmaceutical services in U.S. hospitals in 1989
41. Hospital characteristics and quality of care
42. The effect of regulation, competition, and ownership on mortality rates among hospital inpatients
43. Adjusted hospital death rates; a potential screen for quality of medical care
44. Evaluation of the HCFA model for the analysis of mortality following hospitalization
45. The importance of severity of illness measures in assessing hospital mortality
46. Use of multiple regression in counseling psychology research: A flexible data analytic strategy
47. Use of LOS by professional standards review organizations (PSRO) is an important illustration
48. Evolution of the PSRO hospital review system
49. Cost of pharmaceutical services in U.S. hospitals in 1992
50. Clinical and economic effectiveness of an inpatient anticoagulation service
51. Pharmacist influence on economic outcomes in a tertiary care teaching hospital
52. Effect of pharmacist participation on a medical team on costs, charges, and length of stay
53. The deteriorating administrative efficiency of the United States health care system
54. Costs of care and administration at for-profit and other hospital in the United States
55. Changes in pharmacy, nursing, and total personnel staffing in United States hospitals: 1989-1998
56. The effect of regulation, competition, and ownership on mortality rates among hospital inpatients
57. Predicting hospital-associated mortality for Medicare patients